A Case of Suspected Hyperphenylalaninemia at Newborn Screening by Tandem Mass Spectrometry during Total Parenteral Nutrition
Authors:
- Damiana PieragostinoDamiana Pieragostino
- Ilaria CicaliniIlaria Cicalini
- Silvia Di MicheleSMSilvia Di Michele
- Paola FusilliPFPaola Fusilli
- Giovanna CotugnoGCGiovanna Cotugno
- Rossella FerranteRFRossella Ferrante
- Ines BucciIBInes Bucci
- Carlo Dionisi-ViciCDCarlo Dionisi-Vici
- Liborio StuppiaLSLiborio Stuppia
- Vincenzo De LaurenziVLVincenzo De Laurenzi
- Claudia RossiClaudia Rossi
Open Access
- 24 January 2020
- journal article
- case report
- Published by MDPI AG in Metabolites
- Vol. 10 (2) , 44
Abstract
Phenylketonuria (PKU) is a rare autosomal recessive condition affecting about 1 in 10,000 people in the Europe, with a higher rate in some countries, like Ireland and Italy. In Italy, newborn screening (NBS) by MS/MS allows the diagnostic suspicion of PKU and its variants (Hyperphenylalaninemia (HPA), Tetrahydrobiopterin (BH4) synthesis deficiency, and Tetrahydrobiopterin (BH4) recycling deficiency) through the quantification of Phenylalanine (Phe) and the Phenylalanine/Tyrosine (Phe/Tyr) ratio in dried blood Spot (DBS) samples. Here, we report a case of an HPA whose suspicion was possible with expanded NBS, even if the normal-weight newborn was in total parenteral nutrition (TPN). It is known that TPN may present metabolic alterations, mainly for amino acids at NBS in MS/MS, frequently causing false positives. Actually, TPN is considered a special protocol in NBS, requiring several sample collections. In particular, a DBS sample is required before TPN, at basal time point (48 h after birth) and 72 h after the end of the procedure. In the case we report, even if the first DBS sample (before TPN) resulted negative, the repeated NBS tests revealed increased levels of Phe and dramatically high Phe/Tyr ratio. Thus, the newborn was recalled, and the NBS test was repeated several times before that HPA suspicion was confirmed by other specific biochemical tests. This case highlights the importance of Phe/Tyr ratio, only detectable by MS/MS analysis, in supporting the diagnostic suspicion during amino acids administration in the neonatal period.Keywords
This publication has 21 references indexed in Scilit:
- Highest Plasma Phenylalanine Levels in (Very) Premature Infants on Intravenous Feeding; A Need for ConcernPLOS ONE, 2015
- Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometryAnnals of Pediatric Endocrinology & Metabolism, 2015
- Comparison of tandem mass spectrometry and amino acid analyzer for phenylalanine and tyrosine monitoring—Implications for clinical management of patients with hyperphenylalaninemiaClinical Biochemistry, 2015
- Postanalytical tools improve performance of newborn screening by tandem mass spectrometryGenetics in Medicine, 2014
- Mass spectrometry in clinical chemistry: the case of newborn screeningJournal of Pharmaceutical and Biomedical Analysis, 2014
- Parenteral nutrition in patients with inborn errors of metabolism - a therapeutic problem.2014
- Reduction in newborn screening metabolic false-positive results following a new collection protocolGenetics in Medicine, 2014
- Amino Acid and Acylcarnitine Profiles in Premature Neonates: A Pilot StudyIndian Journal of Pediatrics, 2013
- Extremely high phenylalanine levels in a newborn on parenteral nutrition: phenylketonuria in the neonatal intensive care unitJournal of Perinatology, 2011
- PhenylketonuriaThe Lancet, 2010